LATEST SENATOR BROWN
U.S. Sen. Sherrod Brown is highlighting Dr. Scott Gottlieb’s troubling record on opioids ahead of a markup tomorrow in the Senate Health, Education, Labor and Pensions (HELP) Committee to vote on Gottlieb’s nomination to head the Food and Drug Administration (FDA).
The hearing follows a report from the Washington Post this week, which found that while at FDA in 2006, Gottlieb worked on behalf of the pharmaceutical Cephalon to try to secure additional supply of fentanyl when the company was running low. According to the Post, the company was under investigation at that time for illegally pushing fentanyl for off-label uses.
Read the Full Press Release